CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cyclophosphamide

环磷酰胺 杂质对照品Cyclophosphamide Impurities

EP38 个杂质条目38 impurity entries

本页汇总 环磷酰胺 的 38 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 38 impurity reference standards of Cyclophosphamide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 环磷酰胺(Cyclophosphamide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesCoffee mitigates cyclophosphamide-induced genotoxic damage in Drosophila melanogaster germ cells
    Drug and chemical toxicology · 2019 · Nagpal I, Abraham SK  ·  PMID 29482370  ·  DOI
  2. 杂质研究Impurity studiesAmelioration of the cyclophosphamide induced genotoxic damage in mice by the ethanolic extract of Equisetum arvense
    Toxicology reports · 2017 · Kour J et al.  ·  PMID 28959643  ·  DOI
  3. 杂质研究Impurity studiesProtective effect of thymoquinone against cyclophosphamide-induced genotoxic damage in human lymphocytes
    Bratislavske lekarske listy · 2017 · Yuksel S et al.  ·  PMID 28471230  ·  DOI
  4. 分析方法Analytical MethodsA review on analytical perspectives for cyclophosphamide, its metabolites, and impurities
    Drug metabolism reviews · 2026 · Ahirrao H et al.  ·  PMID 41879329  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of a UPLC-MS/MS method with volumetric absorptive microsampling to quantitate cyclophosphamide and 4-hydroxycyclophosphamide
    Frontiers in pharmacology · 2022 · Harahap Y et al.  ·  PMID 36034779  ·  DOI

环磷酰胺 —— 原料药与杂质对照品Cyclophosphamide — drug substance & impurities

共 39 个条目(含原料药本体)39 items incl. the drug substance
Cyclophosphamide structure
EP原料药 APIAPI
环磷酰胺Cyclophosphamide
Cyclophosphamide
CAS No.50-18-0
Chemical FormulaC7H15Cl2N2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 18 (Cyclophosphamide Monohydrate EP Impurity A) (Mixture of Enantiomers) structure
EPA
环磷酰胺杂质18 (环磷酰胺一水合物 EP杂质A) (对映异构体混合物)Cyclophosphamide Impurity 18 (Cyclophosphamide Monohydrate EP Impurity A) (Mixture of Enantiomers)
Cyclophosphamide Impurity 18 (Cyclophosphamide Monohydrate EP Impurity A) (Mixture of Enantiomers)
CAS No.1797009-12-1
Chemical FormulaC7H16ClN2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 1 (Cyclophosphamide Monohydrate EP Impurity B) (Mixture of Enantiomers) structure
EPB
环磷酰胺杂质1 (环磷酰胺一水合物EP杂质B) (对映异构体混合物)Cyclophosphamide Impurity 1 (Cyclophosphamide Monohydrate EP Impurity B) (Mixture of Enantiomers)
Cyclophosphamide Impurity 1 (Cyclophosphamide Monohydrate EP Impurity B) (Mixture of Enantiomers)
CAS No.22089-17-4
Chemical FormulaC8H17Cl2N2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 2 structure
2
环磷酰胺杂质2Cyclophosphamide Impurity 2
Cyclophosphamide Impurity 2
CAS No.40277-05-2
Chemical FormulaC7H15Cl2N2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 3 structure
3
环磷酰胺杂质3Cyclophosphamide Impurity 3
Cyclophosphamide Impurity 3
CAS No.39800-16-3
Chemical FormulaC7H15Cl2N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 7 structure
7
环磷酰胺杂质7Cyclophosphamide Impurity 7
Cyclophosphamide Impurity 7
CAS No.2810251-24-0
Chemical FormulaC7H18ClN2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 8 structure
8
环磷酰胺杂质8Cyclophosphamide Impurity 8
Cyclophosphamide Impurity 8
CAS No.90632-33-0
Chemical FormulaC7H17N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 9  Monomer structure
9
环磷酰胺杂质9 单体Cyclophosphamide Impurity 9 Monomer
Cyclophosphamide Impurity 9 Monomer
CAS No.10159-53-2
Chemical FormulaC4H11Cl2N2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 9 structure
9
环磷酰胺杂质9Cyclophosphamide Impurity 9
Cyclophosphamide Impurity 9
CAS No.1566-15-0
Chemical FormulaC4H11Cl2N2O2P·C6H13N
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 10 structure
10
环磷酰胺杂质10Cyclophosphamide Impurity 10
Cyclophosphamide Impurity 10
CAS No.36761-83-8
Chemical FormulaC5H12ClN2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 11 structure
11
环磷酰胺杂质11Cyclophosphamide Impurity 11
Cyclophosphamide Impurity 11
CAS No.158401-52-6
Chemical FormulaC7H16ClN2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 12 structure
12
环磷酰胺杂质12Cyclophosphamide Impurity 12
Cyclophosphamide Impurity 12
CAS No.1071-28-9
Chemical FormulaC3H10NO4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 13 Dihydrochloride structure
13
环磷酰胺杂质13 双盐酸盐Cyclophosphamide Impurity 13 Dihydrochloride
Cyclophosphamide Impurity 13 Dihydrochloride
CAS No.158401-51-5
Chemical FormulaC7H18ClN2O4P·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 13 structure
13
环磷酰胺杂质13Cyclophosphamide Impurity 13
Cyclophosphamide Impurity 13
CAS No.45164-26-9
Chemical FormulaC7H18ClN2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 14 structure
14
环磷酰胺杂质14Cyclophosphamide Impurity 14
Cyclophosphamide Impurity 14
CAS No.52336-54-6
Chemical FormulaC7H17Cl2N2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 15 structure
15
环磷酰胺杂质15Cyclophosphamide Impurity 15
Cyclophosphamide Impurity 15
CAS No.3308-51-8
Chemical FormulaC7H17Cl2N2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 16 structure
16
环磷酰胺杂质16Cyclophosphamide Impurity 16
Cyclophosphamide Impurity 16
CAS No.1111-92-8
Chemical FormulaC2H6ClOP
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 17 Monomer structure
17
环磷酰胺杂质17 单体Cyclophosphamide Impurity 17 Monomer
Cyclophosphamide Impurity 17 Monomer
CAS No.32315-92-7
Chemical FormulaC3H8ClN
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 17 structure
17
环磷酰胺杂质17Cyclophosphamide Impurity 17
Cyclophosphamide Impurity 17
CAS No.4535-90-4
Chemical FormulaC3H8ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 19 structure
19
环磷酰胺杂质19Cyclophosphamide Impurity 19
Cyclophosphamide Impurity 19
CAS No.60106-92-5
Chemical FormulaC8H16Cl5N2OP
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 20 structure
20
环磷酰胺杂质20Cyclophosphamide Impurity 20
Cyclophosphamide Impurity 20
CAS No.28319-77-9
Chemical FormulaC8H20NO6P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 22 structure
22
环磷酰胺杂质22Cyclophosphamide Impurity 22
Cyclophosphamide Impurity 22
CAS No.2924754-60-7
Chemical FormulaC9H22ClN2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 23 structure
23
环磷酰胺杂质23Cyclophosphamide Impurity 23
Cyclophosphamide Impurity 23
CAS No.2387771-96-0
Chemical FormulaC9H20ClN2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 25 structure
25
环磷酰胺杂质25Cyclophosphamide Impurity 25
Cyclophosphamide Impurity 25
CAS No.35144-64-0
Chemical FormulaC7H15Cl2N2O3P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 26 structure
26
环磷酰胺杂质26Cyclophosphamide Impurity 26
Cyclophosphamide Impurity 26
CAS No.22788-18-7
Chemical FormulaC7H15Cl2N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 29 (N-NitrosoCyclophosphamide Impurity 17 Monomer) structure
29
环磷酰胺杂质29 (N-亚硝基环磷酰胺杂质17 单体)Cyclophosphamide Impurity 29 (N-NitrosoCyclophosphamide Impurity 17 Monomer)
Cyclophosphamide Impurity 29 (N-NitrosoCyclophosphamide Impurity 17 Monomer)
CAS No.16339-16-5
Chemical FormulaC3H7ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 31 structure
31
环磷酰胺杂质31Cyclophosphamide Impurity 31
Cyclophosphamide Impurity 31
CAS No.33049-08-0
Chemical FormulaC5H14NO6P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 35 structure
35
环磷酰胺杂质35Cyclophosphamide Impurity 35
Cyclophosphamide Impurity 35
CAS No.6909-61-1
Chemical FormulaC3H10NO4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 36 (N-Nitroso Cyclophosphamide Impurity 35) structure
36
环磷酰胺杂质36 (N-亚硝基环磷酰胺杂质35)Cyclophosphamide Impurity 36 (N-Nitroso Cyclophosphamide Impurity 35)
Cyclophosphamide Impurity 36 (N-Nitroso Cyclophosphamide Impurity 35)
CAS No.875136-76-8
Chemical FormulaC3H9N2O5P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 42 structure
42
环磷酰胺杂质42Cyclophosphamide Impurity 42
Cyclophosphamide Impurity 42
CAS No.1673581-55-9
Chemical FormulaC7H16ClN2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 43 structure
43
环磷酰胺杂质43Cyclophosphamide Impurity 43
Cyclophosphamide Impurity 43
CAS No.1025809-83-9
Chemical FormulaC7H16ClN2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 44 structure
44
环磷酰胺杂质44Cyclophosphamide Impurity 44
Cyclophosphamide Impurity 44
CAS No.2387771-94-8
Chemical FormulaC9H21N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 45 structure
45
环磷酰胺杂质45Cyclophosphamide Impurity 45
Cyclophosphamide Impurity 45
CAS No.244757-80-0
Chemical FormulaC7H12F3O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 46 structure
46
环磷酰胺杂质46Cyclophosphamide Impurity 46
Cyclophosphamide Impurity 46
CAS No.67292-62-0
Chemical FormulaC7H15Cl2N2O2P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 47 structure
47
环磷酰胺杂质47Cyclophosphamide Impurity 47
Cyclophosphamide Impurity 47
CAS No.2514696-36-5
Chemical FormulaC9H21N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 48 structure
48
环磷酰胺杂质48Cyclophosphamide Impurity 48
Cyclophosphamide Impurity 48
CAS No.2806361-64-6
Chemical FormulaC11H25N2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 49 structure
49
环磷酰胺杂质49Cyclophosphamide Impurity 49
Cyclophosphamide Impurity 49
CAS No.145429-55-6
Chemical FormulaC8H19O8P
Purity>95%询价On request
10mg25mg50mg100mg
Cyclophosphamide Impurity 10-d4 structure
10-D4
环磷酰胺杂质10-d4Cyclophosphamide Impurity 10-d4
Cyclophosphamide Impurity 10-d4
CAS No.1346600-68-7
Chemical FormulaC5H8D4ClN2O2P
Purity>95%询价On request
Cyclophosphamide Impurity 26-d4 structure
26-D4
环磷酰胺杂质26-d4Cyclophosphamide Impurity 26-d4
Cyclophosphamide Impurity 26-d4
CAS No.1246817-74-2
Chemical FormulaC7H11D4Cl2N2O4P
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

环磷酰胺 —— 研究文献与合成路线Cyclophosphamide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 环磷酰胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cyclophosphamide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1
    Liu L, Liu B, Guan G, et al. · Biochemical and biophysical research communications · 2022 · 被引 26cited 26
  2. Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan
    Hansel S, Castegnaro M, Sportouch MH, et al. · International archives of occupational and environmental health · 1997 · 被引 34cited 34
  3. Biodegradation of cyclophosphamide and etoposide by white rot fungi and their degradation kinetics
    Yadav A, Rene ER, Kanti Mandal M, et al. · Bioresource technology · 2022 · 被引 11cited 11
  4. Microcoated wire sensors for the determination of anticancer drugs cyclophosphamide and ifosphamide in the presence of their degradates
    Hassan SS, Amer MM, Abd El-Fatah SA, et al. · Talanta · 1998 · 被引 8cited 8
  5. A review on analytical perspectives for cyclophosphamide, its metabolites, and impurities
    Ahirrao H, Tatapudi HK, Vatsavai KR · Drug metabolism reviews · 2026
  6. Effects of incompletely degraded galactomannan on growth performance and immune function of cyclophosphamide-induced immunosuppressed broilers
    Zhang J, Diao X, Jiang Y, et al. · Poultry science · 2026

合成与制备工艺专利Synthesis & process patents

  1. Cyclophosphamide liposome and its preparing method
    HU CAIZHONG · 公开号 CN1775218CN1775218 · 2006
  2. Cyclophosphamide compound preparation coataining glycyrrhizin
    LIU FENGMING · 公开号 CN1657049CN1657049 · 2005
  3. Cyclophosphamide quaternary ammonium salt derivant and its synthesis and use
    LI RUNTAO, SUN QI, GE ZEMEI · 公开号 CN1607204CN1607204 · 2005
  4. Derivatives of cyclophosphamide, process for their preparation and their use
    Eibl Hansjörg Prof. Dr., Kolar Cenek Dr., Seiler Friedrich Robert, Sedlacek Hans-Harald Dr · 公开号 EP0072531EP0072531 · 1983
  5. Process for freeze drying cyclophosphamide
    Francis Daniel Lee · 公开号 EP0271622EP0271622 · 1988

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

环磷酰胺 杂质谱研究要点Cyclophosphamide — impurity profiling notes

下面这些是拿到 环磷酰胺 的 39 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 39 impurity entries for Cyclophosphamide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances